ACOG Recommendations Developed for Managing Cancer in Pregnancy

Medically reviewed by Carmen Pope, BPharm. Last updated on March 23, 2026.

via HealthDay

MONDAY, March 23, 2026 -- Recommendations are presented for the management of pregnant patients with cancer in a Society for Maternal-Fetal Medicine Consult Series endorsed by the American College of Obstetricians and Gynecologists and published in the March issue of Pregnancy.

Noting that the incidence of cancer is increasing among reproductive-age individuals, Moti Gulersen, M.D., from the Sidney Kimmel Medical College of Thomas Jefferson University in Philadelphia, and colleagues provide evidence-based recommendations for the medical and obstetric management of patients with cancer.

According to the authors, ultrasonography and noncontrast magnetic resonance imaging (MRI) are suggested as first-line imaging for evaluation of pregnant patients with suspected cancer. If clinically indicated, computed tomography (CT), with or without contrast, gadolinium contrast for MRI, and fluorine-18-fluorodeoxyglucose positron emission tomography plus CT should not be withheld. Thromboprophylaxis initiation is recommended for all patients with active hematological or gynecological cancers during pregnancy; based on individual risk factors, thromboprophylaxis should be considered for all patients with nonhematological or nongynecological cancers during pregnancy. Surgery for cancer treatment should not be delayed or withheld from a pregnant patient at any gestational age. Provided that the patient wants to continue the pregnancy, and that delaying chemotherapy is not expected to significantly change the patient's prognosis compared with initiation immediately after diagnosis, chemotherapy should generally be administered after 12 weeks of gestation. Clinician-initiated preterm delivery should be avoided when possible to improve long-term neurodevelopmental outcomes of children exposed to chemotherapy in utero.

"Cancer treatment will need to be individualized based on the type and stage of cancer, the stage of pregnancy, and our patient's desire to continue the pregnancy," Gulersen said in a statement.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords